StonvexLoading…
StonvexStonvexStonvexCore line items from HRTG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $216.96M | $212.66M | $847.33M | $212.46M | $208.03M |
Operating Income | Not available | $50.82M | $267.15M | $70.17M | $64.87M |
Net Income | Not available | $36.48M | $195.59M | $50.42M | $48.02M |
EPS (Diluted) | $1.20 | $1.19 | $6.32 | $1.63 | $1.55 |
Total Assets | Not available | $2.02B | $2.20B | $2.37B | $2.54B |
Total Liabilities | Not available | $1.50B | $1.69B | $1.93B | $2.15B |
Cash & Equivalents | Not available | $517.07M | $559.27M | $560.43M | $473.46M |
Free Cash Flow OCF − CapEx | Not available | $23.05M | $174.16M | $163.22M | $40.50M |
Shares Outstanding | Not available | 30.33M | 30.83M | 30.91M | 31.02M |